Deliberate lying by corporation officials

Misrepresentation of facts by corporate leaders
Deliberate distortion of corporate news and information
Corporate over-reporting and under-reporting
Perjury by corporation representatives
Fabrication of reports on corporate competitors
Corporate slander

Nature

A company makes false and defamatory statements about a competitor which are harmful to the competitor's reputation.

Background

The global significance of deliberate lying by corporation officials emerged prominently during the 20th century, as high-profile scandals—such as the Enron collapse and Volkswagen emissions case—exposed systemic deception within major companies. Investigative journalism and regulatory inquiries revealed how such misconduct undermined public trust, distorted markets, and prompted international calls for transparency. Over time, the proliferation of whistleblower accounts and legal actions has deepened awareness of the widespread and persistent nature of corporate dishonesty.

Incidence

The global pharmaceutical companies and dozens of generic firms, that make and sell the less-expensive, generic versions of big companies' drugs, are engaged in a fierce competition over the markets. The big companies have underwritten scientific studies damning the safety of generic medicines, spread unsubstantiated tales of ill effects of these drugs.

Claim

Deliberate lying by corporate officials is a grave and urgent problem that undermines public trust, distorts markets, and endangers lives. When those in power choose deception over honesty, they betray employees, customers, and society at large. Such dishonesty fuels corruption, financial crises, and environmental disasters. We must demand accountability and transparency from corporate leaders—anything less threatens the very foundation of ethical business and a just society. This issue cannot be ignored.